![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, July 06, 2022 10:27:51 AM
1) NO MORE JUST BUY & HOLD
2) MUST TRADE AMRN like Denner claims he will do in his 13D "trade anyway you can": BUY, SELL, covered SHORT SELL, naked SHORT SELL, and options (if you're into it)
3) Your basket must include EVFM, this is the TRUE single drug bio company that you've been dreaming about for AMRN since after March 2020. Mark my word! I BOUGHT IN AGAIN and HOLD LONG since last week 150K shares average $1.02. GLTA longs!=)
Here's the ten (10) good catalyst and news for EVFM since just 6/14:
1) June 16: Phexxi® Prevented 99% of Pregnancies Per Act of Intercourse. https://evofem.investorroom.com/2022-06-16-Phexxi-R-Prevented-99-of-Pregnancies-Per-Act-of-Intercourse-in-a-Post-Hoc-Analysis-of-Phase-3-AMPOWER-Clinical-Trial-Data
2) June 24: USnews' Great article about Phexxi https://health.usnews.com/wellness/articles/non-hormonal-birth-control-options?utm_source=usn_tw&utm_campaign=tw_health
3) June 28: Evofem Reaches Agreement with One of the Largest PBM. https://evofem.investorroom.com/2022-06-28-Evofem-Reaches-Agreement-with-One-of-the-Largest-Pharmacy-Benefit-Managers-in-the-U-S-for-Access-to-Phexxi-R
4) June 30: BRAND NEW Patent granted. https://evofem.investorroom.com/2022-06-30-Evofem-Strengthens-Phexxi-R-Intellectual-Property-with-New-Composition-of-Matter-Patent-From-USPTO
5) Evaluation of EVO100 Clinical Trial results by 7/28/22.https://clinicaltrials.gov/ct2/show/NCT04553068
6) July 01: Excellent Reuter's article about EVFM & Roe v Wade https://www.reuters.com/world/us/us-abortion-ruling-ignites-retail-interest-women-contraceptive-makers-vanda-2022-07-01/
7) July 02: Joe Biden's tweet about contraception.
We will protect a woman’s access to medications approved by the FDA, like contraception, which is essential for preventative health care, and have taken steps to ensure that these critical medications are available to the fullest extent possible.
— Joe Biden (@JoeBiden) July 2, 2022
8) July 03: Seeking Alpha's tweet about CEO interview this week
@EvofemBiosciences CEO @Saundraceo joins us next week to discuss #hormone-free #contraceptives for women and #investing implications of the #RoevWade reversal
— Seeking Alpha (@SeekingAlpha) July 3, 2022
Subscribe to Seeking Alpha's @CeoInterviews to receive notifications about new episodes: https://t.co/Paukw9Eo6S pic.twitter.com/2KX3Jtoulc
9) July 03: Reddit's Short Squeeze https://www.reddit.com/r/Shortsqueeze/comments/vql76v/evfm_roe_v_wade_overturn_for_evfm_product_phexxi/?utm_source=share&utm_medium=web2x&context=3
10) EVFM is NUMBER ONE (#1) on Fintel Gamma Squeeze https://fintel.io/gammaSqueeze
Recent AMRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM